FDA Nanotech Task Force Schedules October Meeting
ePT--the Electronic Newsletter of Pharmaceutical Technology
On Oct. 10, the US Food and Drug Administration (Rockville, MD) will hold a public meeting on products containing nanotechnology materials.
On Oct. 10, the US Food and Drug Administration (Rockville, MD, www.fda.gov) will hold a public meeting on products containing "nanotechnology materials."
The Agency's new Nanotechnology Task Force stated "we are interested in learning about the kinds of new nanotechnology material products under development in the areas of foods (including dietary supplements), food and color additives, animal feeds, cosmetics, drugs and biologics, and medical devices," according to the meeting announcement. The announcement, "Food and Drug Administration-Regulated Products Containing Nanotechnology Materials; Public Meeting" (Docket No. 2006N-0107) is scheduled for publication in the Aug. 11 Federal Register (with a preview draft posted online at http://www.fda.gov/OHRMS/DOCKETS/98fr/06n-0107-nm00002.pdf).
The meeting will be held at the Natcher Auditorium at the National Institutes of Health, 9000 Rockville Pike, Building 45, Bethesda, MD. Those who would like to attend should register at the Nanotechnology Task Force's Web page,
www.fda.gov/nanotechnology/
, which will also post additional background material and the meeting agenda.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
